Sanofi Consumer Healthcare India Limited reported a 7 per cent year-on-year increase in revenue for the second quarter of FY26, with revenue from operations reaching Rs. 2,357 million, supported by strong domestic market performance and brand relaunch initiatives.

The company posted a 16 per cent rise in Profit Before Tax (PBT) to Rs. 919 million during the quarter ended June 2026. Domestic sales grew 12 per cent, aided by relaunch activities, while export sales declined 9 per cent on a high base.

For the first half of FY26, the company reported 18 per cent growth in revenue from operations to Rs. 4,649 million. Domestic sales increased 14 per cent, while export sales rose 27 per cent on a comparatively low base. Profit Before Tax for the half year was up 25 per cent compared with the corresponding period last year.

Commenting on the results, Himanshu Bakshi, Managing Director, Sanofi Consumer Healthcare India Limited, said, "Our performance this quarter reflects the disciplined execution on all fronts. Our targeted investments behind our brands and go-to-market capabilities are translating into profitable growth and market share gains in most of our brands, reinforcing our confidence in the strength of our strategy."

The company attributed its quarterly performance to sustained investments in its brands and commercial capabilities, which helped drive profitable growth and strengthen market share across key product categories.